SGCB and breast carcinoma: Recent studies show that sGC expression is deficient in human breast cancer cells [141,208] and overexpression of α1 and β1, the two most common sGC subunits, inhibited the growth of both MDA-MB-231 cells and MDA-MB-231 xenografts in nude mice [208].